Vendors, hospital officials anchor corrupt healthcare culture in China

A culture of corruption allows giant companies like General Electric, Siemens, Philips and Toshiba to bribe Chinese government and hospital officials into purchasing expensive medical equipment, including imaging modalities, according to a lengthy piece published by the New York Times.

The Times analyzed dozens of Chinese court cases and internal corporate documents alongside interviews with insiders for their story. In one case filed in 2016, a hospital administrator—Wu Dagong— was offered more than $1 million by two GE sales representatives to close the sale of a $4 million CT scanner.

In that case, “Mr. Wu also took a bribe — the $220,000 in bricks of bills packed in a suitcase — from a G.E. sales contractor, who walked with Mr. Wu to his car and left the suitcase in the trunk. Mr. Wu was sentenced to 15 years.”

After its all said and done, the people of China are the ones who feel the cost of corruption as prices for equipment sold to hospitals are inflated by 50% or more in some cases, according to the Times reporting.

Earlier this month, Reuters reported that the U.S. Securities and Exchange Commission was investigating Siemens AG, Philips NV and General Electric over potentially using intermediaries to set up bribes with Chinese government and hospital officials to sell medical equipment.

Read the entire New York Times story below.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.